» Articles » PMID: 6300083

1 Alpha,25-dihydroxyvitamin D3 Receptors in Cultured Rat Osteoblast-like Cells. Glucocorticoid Treatment Increases Receptor Content

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1983 Apr 10
PMID 6300083
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The direct actions of 1 alpha,25-dihydroxyvitamin D3 (1,25(OH)2D3) in target cells are initiated by the binding of hormone to specific receptor sites. The aims of this study were to characterize the receptor for 1,25(OH)2D3 in cultured rat osteoblast-like (OB) cells and to determine whether these receptors are regulated by either the culture cycle itself or glucocorticoid treatment. The 1,25(OH)2D3 receptor in rat OB cells exhibited the same apparent binding affinity (Kd = 0.1 nM) and sedimentation coefficient (3.2 S) as mouse OB cells and receptors in other target organs. However, the receptor concentration in rat OB cells was substantially lower than mouse OB cells (approximately 20%). The concentration of receptors in rat OB cells did not show a correlation with the rate of DNA synthesis and therefore did not exhibit an endogenous rhythm in receptor concentration as was previously seen in mouse OB cells. Also in contrast to mouse cells, where glucocorticoids caused a decrease in receptor level, dexamethasone induced a marked increase in receptor binding throughout the culture cycle. This increase was due to an increase in receptor number with no change in receptor affinity. The change was glucocorticoid-specific, dose-dependent with half-maximal stimulation occurring between 1.3 and 13 nM and exhibited a latent period of at least 4 h. The independence of receptor concentration from DNA synthesis rate was established by assessing receptors after stimulating cell proliferation with epidermal growth factor and inhibiting it with hydroxyurea. Neither treatment altered basal 1,25(OH)2D3 receptor concentration or prevented the marked increase in receptor levels elicited by dexamethasone. We conclude that although the biochemical characteristics of 1,25(OH)2D3 receptors are indistinguishable in rat and mouse OB cells, there are genuine species differences in the regulation of the receptor number as it relates to DNA synthesis rate and response to glucocorticoids.

Citing Articles

Vitamin D and the Central Nervous System: Causative and Preventative Mechanisms in Brain Disorders.

Cui X, Eyles D Nutrients. 2022; 14(20).

PMID: 36297037 PMC: 9610817. DOI: 10.3390/nu14204353.


Valproate and Short-Chain Fatty Acids Activate Transcription of the Human Vitamin D Receptor Gene through a Proximal GC-Rich DNA Region Containing Two Putative Sp1 Binding Sites.

Moreno-Torres M, Guzman C, Petrov P, Jover R Nutrients. 2022; 14(13).

PMID: 35807853 PMC: 9268083. DOI: 10.3390/nu14132673.


Vitamin D: Brain and Behavior.

Eyles D JBMR Plus. 2021; 5(1):e10419.

PMID: 33553986 PMC: 7839822. DOI: 10.1002/jbm4.10419.


Synthesis of calbindin-D28K during mineralization in human bone marrow stromal cells.

Faucheux C, Bareille R, Amedee J Biochem J. 1998; 333 ( Pt 3):817-23.

PMID: 9677345 PMC: 1219649. DOI: 10.1042/bj3330817.


17 beta-estradiol increases the receptor number and modulates the action of 1,25-dihydroxyvitamin D3 in human osteosarcoma-derived osteoblast-like cells.

Ishibe M, Nojima T, Ishibashi T, Koda T, Kaneda K, Rosier R Calcif Tissue Int. 1995; 57(6):430-5.

PMID: 8581875 DOI: 10.1007/BF00301946.